title: ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes.
authors.affiliation: University of Toronto, Toronto, Ontario, Canada.
authors.forename: Lorraine
authors.initials: L
authors.lastname: Lipscombe